In addition, we analyzed gene expression of the anti-apoptotic molecule Bcl2 (B cell lymphoma 2), and the alarmin Hmgb1 (high mobility group box 1), which has been reported to be of predictive value for HNSCC outcome [20]. This evidence concerns the gene HMGB1 and head and neck squamous cell carcinoma.